Labcorp Holdings Inc.
LH Healthcare Diagnostics & Research
Labcorp Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.0 billion, up 7.25% from fiscal 2024. In the quarter to June 2026, revenue grew 5.78%, EPS grew 28.4%, free cash flow fell 42.0% and total debt rose 15.1%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years, revenue growth for three.
Follow LH
Labcorp Holdings Inc. (LH) EPS (diluted)
Labcorp Holdings Inc.'s EPS (diluted) for fiscal 2025 was $10.46, up 18.3% from $8.84 in fiscal 2024. Over the twelve months to 30 June 2026 it was $12.09. Over the past ten years it has ranged from $4.34 (fiscal 2015) to $24.39 (fiscal 2021); the current reading is higher than 64% of that period. Labcorp Holdings Inc. ranks 6th of 52 Diagnostics & Research companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | $10.46 | 18.33% |
| FY2024 | $8.84 | 85.32% |
| FY2023 | $4.77 | (65.86%) |
| FY2022 | $13.97 | (42.72%) |
| FY2021 | $24.39 | 53.59% |
| FY2020 | $15.88 | 90.18% |
| FY2019 | $8.35 | (3.02%) |
| FY2018 | $8.61 | (29.48%) |
| FY2017 | $12.21 | 73.93% |
| FY2016 | $7.02 | 61.75% |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Jun 2026 | $3.64 | 8.66% |
| Mar 2026 | $3.35 | 69.19% |
| Dec 2025 | $1.98 | (36.54%) |
| Sep 2025 | $3.12 | 9.86% |
| 42 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| MTD Mettler-Toledo International, Inc. compare | $44.43 |
| MEDP Medpace Holdings, Inc. compare | $17.06 |
| IDXX IDEXX Laboratories, Inc. compare | $14.22 |
| LH Labcorp Holdings Inc. | $12.09 |
| DGX Quest Diagnostics Incorporated compare | $9.42 |
| ILMN Illumina, Inc. compare | $5.36 |
| WAT Waters Corporation compare | $4.01 |
| RVTY Revvity Inc. compare | $2.10 |
| GH Guardant Health, Inc. compare | −$3.49 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on LH
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement